Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation

Journal of Molecular Biology

Volumn 288, Issue 1, 1999, Pages 41-56

  Ivanov, Dmitri ^a   Kwak, Youn Tae ^a   Nee, Eugene ^a   Guo, Jun ^a   García Martínez, León F ^a   Gaynor, Richard B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CDK9; Cyclin T; HIV; P TEFb; Tat

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; RECOMBINANT PROTEIN; RNA; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN RNA BINDING; REGULATOR GENE; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS MUTANT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0033597175     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2663     Document Type: Article

References (65)

1. Akoulitchev S., Makela T. P., Weinberg R. A., Reinberg D. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature. 377:1995;557-560.
2. Alonso A., Derse D., Peterlin B. M. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66:1992;4617-4621.
3. Andersen G., Busso D., Poterszman A., Hwang J. R., Wurtz J.-M., Ripp R., Thierry J.-C., Egly J.-M., Moras D. The structure of cyclin H: common mode of kinase activation and specific features. EMBO J. 16:1997;958-967.
4. Chun R. F., Jeang K. T. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271:1996;27888-27894.
5. Cujec T. P., Cho H., Maldonado E., Meyer J., Reinberg D., Peterlin B. M. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell Biol. 17:1997a;1817-1823.
6. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997b;2645-2657.
7. Dahmus M. E. Phosphorylation of mammalian RNA polymerase II. Methods Enzymol. 273:1996;185-193.
8. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11:1983;1475-1489.
9. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. Human immunodeficiency virus 1 Tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl Acad. Sci. USA. 86:1989;6925-6929.
10. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:1990;4145-4153.
11. Feinberg M. B., Baltimore D., Frankel A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl Acad. Sci. USA. 88:1991;4045-4049.
12. Feng S., Holland E. C. HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature. 334:1988;165-167.
13. Fisher R. P., Morgan D. O. A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase. Cell. 78:1994;713-724.
14. Garber M. E., Wei P., KewalRamani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527.
15. Garcia J. A., Harrich D., Soultanakis E., Wu F., Mitsuyasu R., Gaynor R. B. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:1989;765-778.
16. García-Martínez L. F., Ivanov D., Gaynor R. B. Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem. 272:1997a;6951-6958.
17. García-Martínez L. F., Mavankal G., Neveu J., Lane W., Sigman D., Ivanov D., Gaynor R. B. Purification of a Tat associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:1997b;2836-2850.
18. Gold M. O., Yang X., Herrmann C. H., Rice A. P. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivationinvivo. J. Virol. 72:1998;4448-4453.
19. Graeble M. A., Churcher M. J., Lowe A. D., Gait M. J., Karn J. Human immunodeficiency virus type-1 trans -activator protein, tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc. Natl Acad. Sci. USA. 90:1993;6184-6188.
20. Grana X., De Luca A., Sang N., Fu Y., Claudio P. P., Rosenblatt J., Morgan D. O., Giordano A. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl Acad. Sci. USA. 91:1994;3834-3838.
21. Hart C. E., Ou C. Y., Galphin J. C., Moore J., Bacheler L. T., Wasmuth J. J., Petteway S. J., Schochetman G. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science. 246:1989;488-491.
22. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
23. Herrmann C. H., Gold M. O., Rice A. P. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. Nucl. Acids Res. 24:1996;501-508.
24. Jones K. A. Taking a new TAK on Tat transactivation. Genes Dev. 11:1997;2593-2599.
25. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
26. Kao S. Y., Calnan A. F., Luciw P. A., Peterlin B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 330:1987;489-493.
27. Kato H., Sumimoto H., Pognonec P., Chen C. H., Rosen C. A., Roeder R. G. HIV-1 Tat acts as a processivity factor invitro in conjunction with cellular elongation factors. Genes Dev. 6:1992;655-666.
28. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl Acad. Sci. USA. 93:1996;2505-2510.
29. Keen N. J., Churcher M. J., Karn J. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16:1997;5260-5272.
30. Kwak Y. T., Ivanov D., Nee E., Guo J., Nee E., Gaynor R. B. Role of the human and murine cyclin T proteins in regulating HIV-1 Tat transactivation. J. Mol. Biol. 288:1999;57-70.
31. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 59:1989;283-292.
32. Lu H., Flores O., Weinmann R., Reinberg D. The nonphosphorylated form of RNA polymerase II preferentially associates with the preinitiation complex. Proc. Natl Acad. Sci. USA. 88:1991;10004-10008.
33. Lu H., Zawel L., Fisher L., Egly J.-M., Reinberg D. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature. 358:1992;641-645.
34. Madore S. J., Cullen B. R. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:1993;3703-3711.
35. Mancebo H. S. Y., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1997;2633-2644.
36. Marciniak R. A., Sharp P. A. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:1991;4189-4196.
37. Marshall N. F., Price D. H. Control of formation of two district classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12:1992;2078-2090.
38. Marshall N. F., Price D. H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:1995;12335-12338.
39. Marshall N. F., Peng J., Xie P., Price D. H. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183.
40. Mavankal G., Ou S. H. I., Oliver H., Sigman D., Gaynor R. B. HIV-1 and HIV-2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl Acad. Sci. USA. 93:1996;2089-2094.
41. Newstein M., Stanbridge E., Casey G., Shank P. R. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat -mediated trans activation in rodent cells. J. Virol. 64:1990;4565-4567.
42. O'Brien T., Hardin S., Greenleaf A., Lis J. T. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature. 370:1994;75-77.
43. Okamoto H., Sheline C. T., Corden J. L., Jones K. A., Peterlin B. M. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl Acad. Sci. USA. 93:1996;11575-11579.
44. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
45. Pascal E., Tjian R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1991;1646-1656.
46. Peng J., Zhu Y., Milton J. T., Price D. H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762.
47. Ratnasabapathy R., Sheldon M., Johal L., Hernandez N. The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes Dev. 4:1990;2061-2074.
48. Reinberg D., Roeder R. G. Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE. J. Biol. Chem. 262:1987;3310-3321.
49. Rosen C. A., Sodoroski J. G., Haseltine W. A. The location of cis -acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 41:1985;813-823.
50. Roy S., Delling U., Chen C.-H., Rosen C. A., Sonenberg N. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans -activation. Genes Dev. 4:1990;1365-1373.
51. Selby M. J., Bain E. S., Luciw P. A., Peterlin B. M. Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat. Genes Dev. 3:1989;547-558.
52. Sheline C. T., Milocco L. H., Jones K. A. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:1991;2508-2520.
53. Trigon S., Serizawa H., Conaway J. W., Conaway R. C., Jackson S. P., Morange M. Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J. Biol. Chem. 273:1998;6769-6775.
54. Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa I. Evidence that P-TEFb alleviates the negative eff4ect of DSIF on RNA polymerase II-dependent transcaription in vitro. EMBO J. 17:1998;7395-7403.
55. Weeks J. R., Hardin S. E., Shen J., Lee J. M., Greenleaf A. L. Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. Genes Dev. 7:1993;2329-2344.
56. Wei P., Garber M. E., Fang S.-M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
57. Wu F., Garcia J., Sigman D., Gaynor R. B. Tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes Dev. 5:1991;2128-2140.
58. Wu-Baer F., Lane W., Gaynor R. B. The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA. EMBO J. 14:1995a;5995-6009.
59. Wu-Baer F., Sigman D., Gaynor R. B. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl Acad. Sci. USA. 92:1995b;6213-6217.
60. Wu-Baer F., Lane W. S., Gaynor R. B. Role of the human homologues of the yeast transcription factors SPT5 and SPT6 in HIV-1 Tat-activation. J. Mol. Biol. 277:1998;179-197.
61. Yang X., Herrmann C. H., Rice A. P. The human immunodeficiency virus Tat proteins specifically associate with TAK invivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:1996;4576-4584.
62. Zhou Q., Sharp P. A. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:1995;321-328.
63. Zhou Q., Sharp P. A. Tat-SF1: cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
64. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;3681-3691.
65. Zhu Y., Pery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.